|
|
| (11) | Number of the document | C 2459208 |
| (68) | Number of the document | 2459208 |
| (21) | Application number for Supplementary Protection Certificate | PA 2017 007 |
| (22) | Date of filing the application | 2017-03-10 |
| (41) | Date of publication of the application | 2017-03-27 |
| Date of publication of SPC | 2021-07-12 | |
| (24) | Date of coming into effect of SPC | 2030-07-30 |
| (71) |
Kai Pharmaceuticals, Inc.,
270 Littlefield Avenue, South San Francisco, CA 94080,
US
|
| (73) |
Kai Pharmaceuticals, Inc.,
270 Littlefield Avenue, South San Francisco, CA 94080,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (93) | EU/1/16/1142, 2016-11-11 |
| (94) | 2031-11-15 |
| (95) | Etelkalcetidas arba jo druska, įskaitant etelkalcetido hidrochloridą |
| SPC granted |